Tag: Infectious diseases

BTD for FInch’s C. Difficile Drug

Finch Therapeutics Group has secured breakthrough therapy designation from the US Food and Drug Administration (FDA) for its investigational drug CP101 to treat patients with recurrent Clostridium dif...

Bioharmony and Boehringer Ingelheim to Develop MDR Infections Treatment

Bioharmony Therapeutics, a biopharmaceutical company focusing on the development of novel therapeutics for hard to treat bacterial infections, has entered into a collaborative research and licensing a...